Ultragenyx Pharmaceutical (RARE) Asset Utilization Ratio (2017 - 2026)
Ultragenyx Pharmaceutical's Asset Utilization Ratio came in at 0.56 for Q2 2026, up 20.2% from 0.47 a year earlier and up 18.2% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
For FY2025, Ultragenyx Pharmaceutical's Asset Utilization Ratio was 0.44, up 18.6% from FY2024.
- Asset Utilization Ratio has increased in each of the last seven years.
- Going back by year, Asset Utilization Ratio was 0.37 in FY2024 (+30.9%), 0.29 in FY2023 (+20.7%), 0.24 in FY2022 (+10.6%) and 0.21 in FY2021 (+14.4%).
- The Q2 2026 figure represents the highest quarterly Asset Utilization Ratio in data going back to Q3 2017.
- Year-over-year, Asset Utilization Ratio has increased for 14 consecutive quarters, with growth averaging 26.6% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q3 2025 (growth of 52.6%), and the weakest in Q3 2022 (a decline of 2.6%).
- Business Quant data shows RARE's Asset Utilization Ratio at 0.47 (Q1 2026), 0.49 (Q4 2025) and 0.51 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 0.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.56 |
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.42 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | 0.33 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | 0.23 |
| Sep 30, 2021 | 0.24 |
API Access
Ultragenyx Pharmaceutical Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();